Novavax | sciencenewsnet.in

Breaking News

Argonne National Laboratory and the University of Illinois Chicago launch the George Crabtree Institute for Discovery and Sustainability

What women want: Female experiences to manage pelvic pain

Predicting Ovarian Cancer Relapse

Octopus Inspires New Suction Mechanism for Robots

Opioid dependence remains high but stable in Scotland, new surveillance report finds

MSU expert: The cicadas are coming

Soil Bacteria Link their Life Strategies to Soil Conditions

Cleveland Clinic Launches New Women’s Comprehensive Health and Research Center

Telemedicine Can Help Change Care for the Better — If We Get the Rules Right

Researcher studying worst western US megadrought in 1,200 years

18 Apr, 2024

CoVPN Trial: Novavax’s Traditional COVID-19 Vaccine Correlates to Strong Antibody Response, Protection Against SARS-CoV-2

June 28, 2022 sarah JonasResearch Results

A new analysis of the Novavax PREVENT-19 clinical trial concluded that this recombinant protein vaccine produced an antibody response comparable to mRNA vaccines and, if authorized, could help bolster global vaccine supplies. This is the first study to directly support antibody correlates of protection for a recombinant protein COVID-19 vaccine.

Data and safety review board reports how it monitored the COVID-19 vaccine trials

June 15, 2021 sarah JonasResearch Results

Evaluation of three vaccine candidates during the COVID-19 pandemic fell to 12 experts of the federally appointed COVID-19 Vaccine Data and Safety Monitoring Board. This team has now taken the unusual step of publishing details of their review process in The Journal of Infectious Diseases.